Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 10184 Neoplasms 7810 Carcinoma, Non-Small-Cell Lung 5760 Prostatic Neoplasms 5024 Colorectal Neoplasms 4606 Lung Neoplasms 3725 Leukemia, Myeloid, Acute 3102 Neoplasm Metastasis 3083 Multiple Myeloma 3082 Pancreatic Neoplasms 2845 Melanoma 2653 Ovarian Neoplasms 2573 Lymphoma 2571 Carcinoma, Hepatocellular 2480 Stomach Neoplasms 2330 Recurrence 2230 Head and Neck Neoplasms 2103 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086 Lymphoma, Non-Hodgkin 2058 Leukemia 2013 Brain Neoplasms 1905 Glioblastoma 1797 Colonic Neoplasms 1791 Leukemia, Lymphocytic, Chronic, B-Cell 1771 Rectal Neoplasms 1720 Uterine Cervical Neoplasms 1693 Squamous Cell Carcinoma of Head and Neck 1654 Lymphoma, Follicular 1652 Lymphoma, Large B-Cell, Diffuse 1597 Carcinoma, Renal Cell 1577

Interventions

Interleukin-15 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × High-risk Leukemias × Clear all

NCT05304754 2025-04-06

PHINK

Instituto de Investigación Hospital Universitario La Paz

Phase 1/2 Active not recruiting

Other hematologic neoplasm

High-risk Leukemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡